Holen Sie sich die Stockscreener-App
5.61
0.54%
0.03
Generation Bio Co Aktie (GBIO) Neueste Nachrichten
Satellos Bioscience Welcomes New Chief Development Officer - GuruFocus
Satellos taps ex-Generation Bio COO to steer Duchenne trial plans - Stock Titan
Returns Recap: How liquid is NCC.PRBC stockIPO Watch & Smart Money Movement Tracker - baoquankhu1.vn
S P Trends: Why is Generation Bio Co stock going down2025 AllTime Highs & Smart Investment Allocation Insights - baoquankhu1.vn
Halper Sadeh LLC Encourages DHIL, GBIO, CTGO Shareholders to Contact the Firm to Discuss Their Rights - Finviz
Halper Sadeh Investigates Shareholder Rights Violations at Diamond Hill, Generation Bio, and Contango - Intellectia AI
Investor Mood: Is Generation Bio Co a defensive stockTrade Entry Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Gap Down: Whats next for Generation Bio Co stockBreakout Watch & Long-Term Growth Plans - baoquankhu1.vn
Profit Review: Is Gen Digital Inc. in a long term uptrendEntry Point & Technical Pattern Based Signals - baoquankhu1.vn
Hedge Fund Moves: Is Generation Bio Co benefiting from innovation trendsWeekly Profit Report & Free Reliable Trade Execution Plans - baoquankhu1.vn
Growth Value: Is Generation Bio Co benefiting from innovation trendsTake Profit & Daily Chart Pattern Signals - baoquankhu1.vn
Retail Surge: Can Vivid Seats Inc expand into new marketsJuly 2025 Review & Risk Managed Trade Strategies - baoquankhu1.vn
Aug Levels: Can Generation Bio Co grow without external fundingWeekly Trend Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Halper Sadeh LLC Encourages CTGO, GBIO, CDE Shareholders to Contact the Firm to Discuss Their Rights - The Malaysian Reserve
Aug PostEarnings: Will Generation Bio Co outperform small cap indexesTrade Entry Summary & Daily Stock Trend Reports - baoquankhu1.vn
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—FFWM, CFLT, GBIO, and CTGO - GlobeNewswire Inc.
Generation Bio Co. (NASDAQ:GBIO) Receives Average Rating of “Hold” from Analysts - Defense World
Can Generation Bio Co. stock sustain institutional interestBear Alert & Free Community Consensus Stock Picks - ulpravda.ru
Can Generation Bio Co. stock sustain revenue growthJuly 2025 Update & Growth Focused Entry Reports - Улправда
Can Generation Bio Co. stock weather global recessionJuly 2025 Rallies & Free Weekly Watchlist of Top Performers - ulpravda.ru
Generation Bio (NASDAQ:GBIO) Stock Price Down 0.4% – Here’s What Happened - Defense World
What analysts say about Generation Bio Co stockMarket Sentiment Extremes & These Picks Are Just One Breakout Away - earlytimes.in
Generation Bio (GBIO) price target decreased by 70.88% to 9.01 - MSN
Deal Watch: Boehringer Signs On For Rectify’s Chronic Kidney Disease Assets - Citeline News & Insights
Jefferies downgrades Generation Bio (GBIO) - MSN
Generation Bio trading halted, news pending - MSN
Patterns Watch: Can Generation Bio Co stock sustain revenue growthTrade Analysis Report & Weekly Stock Performance Updates - moha.gov.vn
How Generation Bio Co. stock reacts to global recession fearsTrade Analysis Summary & Daily Entry Point Trade Alerts - Улправда
Brokerages Set Generation Bio Co. (NASDAQ:GBIO) PT at $9.25 - Defense World
Why Generation Bio Co. stock remains on buy listsEarnings Trend Report & Real-Time Volume Triggers - DonanımHaber
Why Generation Bio Co. stock is rated strong buyDividend Hike & Target Return Focused Picks - Улправда
Is Generation Bio Co. stock a safe buy before earningsJuly 2025 Chart Watch & Fast Gaining Stock Reports - Улправда
Retail Trends: Why Generation Bio Co. stock is rated strong buyJuly 2025 Volume & Long Hold Capital Preservation Tips - Улправда
Generation Bio stock rating reiterated at Market Perform by Citizens - Investing.com South Africa
Generation Bio trading resumes - MSN
Generation Bio announces merger with XOMA Royalty - MSN
Generation Bio stock rating reiterated at Market Perform by Citizens By Investing.com - Investing.com Canada
Generation Bio (NASDAQ:GBIO) Given a $5.50 Price Target at Wedbush - Defense World
Wedbush Upgrades Generation Bio (GBIO) - Nasdaq
Generation Bio (GBIO) Price Target Increased by 13.40% to 30.94 - MSN
Generation Bio (GBIO) Rating Update: Wedbush Upgrades to Outperf - GuruFocus
NodThera appoints Geoff McDonough, M.D., as independent board member - marketscreener.com
GBIO Downgraded by Jefferies with Price Target Cut by 54.55% | G - GuruFocus
‘Zombie’ biotech buyer Xoma to acquire Generation Bio - BioPharma Dive
Wedbush Upgrades Generation Bio to Outperform From Neutral, Adjusts Price Target to $5.50 From $7 - marketscreener.com
Jefferies Downgrades Generation Bio to Hold From Buy, Adjusts Price Target to $5 From $11 - marketscreener.com
Hold Rating on XOMA’s Acquisition of Generation Bio: Balancing Immediate Cash Offer with Potential Future Returns - TipRanks
Jefferies downgrades Generation Bio stock to Hold as XOMA acquisition announced - Investing.com Nigeria
XOMA Strikes Deal To Acquire Generation Bio, Expanding Royalty Portfolio - Nasdaq
XOMA to Acquire Generation Bio (GBIO) in Strategic Merger - GuruFocus
XOMA royalty to acquire Generation Bio - MSN
XOMA Royalty to Acquire Generation Bio - citybiz
The Ademi Firm Investigates Whether Generation Bio Co. Is Obtaining a Fair Price for Its Public Shareholders - 富途牛牛
GBIO Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Generation Bio Co. is Fair to Shareholders - The AI Journal
Generation Bio Announces Merger with XOMA Royalty - TipRanks
0.89%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):